Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

593.25 +1.72 (+0.29%)
Streaming Delayed Price Updated: 10:09 AM EST, Nov 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 355,161
Open 592.00
Bid (Size) 592.87 (2)
Ask (Size) 593.25 (1)
Prev. Close 591.53
Today's Range 590.78 - 594.61
52wk Range 302.14 - 629.97
Shares Outstanding N/A
Dividend Yield 0.76%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Lilly's Weight-Loss Drug Wallops Novo's In Head-To-Head Study; Novo Stock Dives
The study examined health care records for more than 41,000 people. 
Via Investor's Business Daily
Elliott Wave Technical Analysis: Eli Lilly & Co.
Looking for a triangle in wave (b) as we seem to be near the end of the correction. 
Via Talk Markets

Performance

YTD
+62.54%
+62.54%
1 Month
+4.87%
+4.87%
3 Month
+7.10%
+7.10%
6 Month
+38.86%
+38.86%
1 Year
+62.19%
+62.19%

More News

Read More
Eli Lilly's Blockbuster Mounjaro Shows Larger, Faster Weight Loss Than Novo Nordisk's Ozempic In Real World Study
Via Benzinga
Biotech And Healthcare Portfolio Playbook For December 2023/24
Via Talk Markets
Novo Nordisk's Flexible Pricing Approach: Push for Broader Access, Innovative Payments
Via Benzinga
$1000 Invested In Eli Lilly 10 Years Ago Would Be Worth This Much Today
Via Benzinga
The Best Stocks to Invest $5,000 in Right Now
Via The Motley Fool
Uncovering Noteworthy Technical Analysis Findings for ELI LILLY & CO (NYSE:LLY).
Via Chartmill
Analyst Expectations for Eli Lilly's Future
Via Benzinga
3 Top Stocks That'll Make Smart Investors Rich
Via The Motley Fool
Is Pfizer Stock a Buy Ahead of This Highly Anticipated Weight Loss Readout?
Via The Motley Fool
3 Fantastic Dividend Stocks to Buy Sooner Rather Than Later
Via The Motley Fool
Google Leads Five S&P 500 Stocks Near Buy Points
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Could Ozempic Harm These 3 Medical Device Stocks?
Via The Motley Fool
A Look Into Eli Lilly Inc's Price Over Earnings
Via Benzinga
$3,000 Invested in These 3 Top Stocks Could Make You Rich in 10 Years
Via The Motley Fool
Will Eli Lilly Be Worth More Than Tesla by 2027?
Via The Motley Fool
3 Healthcare Stocks to Scoop Up as They Change the Medical Landscape
Via InvestorPlace
Eli Lilly and Novo Nordisk Are Big Names in Weight Loss, but Investors Shouldn't Count Out This Healthcare Giant
Via The Motley Fool
Alzheimer's Disease Vaccines: Promising Developments, Renewed Enthusiasm From Biogen, Eli Lilly And Others
Via Benzinga
Magnificent 7 Take Center Stage In Hedge Fund Portfolios: Analysts Warn Of Extreme Concentration
Via Benzinga
Can Weight-Loss Drug Ozempic Tip The Scales For Tema's New Healthcare ETF?
Via Benzinga
Topics ETFs
Ignore Eli Lilly. These 2 Stocks Are Better Buys Right Now
Via The Motley Fool
Eli Lilly Just Got One Step Closer to Dethroning Ozempic. Time to Buy the Stock?
Via The Motley Fool
Exposures Product Safety
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.